T-ALLs Prognostic and oncogenic relevance of TLX1/HOX11 expression level in
暂无分享,去创建一个
J. Soulier | E. Clappier | H. Dombret | E. Macintyre | J. Bergeron | X. Thomas | V. Asnafi | A. Buzyn | I. Radford | P. Ballerini | Corinne Millien | G. Soler
[1] H. Dombret,et al. Towards a Pediatric Approach in Adults with Acute Lymphoblastic Leukemia (ALL): The GRAALL-2003 Study. , 2006 .
[2] C. Bloomfield,et al. High expression of the ETS transcription factor ERG predicts adverse outcome in acute T-lymphoblastic leukemia in adults. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] A. Hagemeijer,et al. Cytogenetics and molecular genetics of T-cell acute lymphoblastic leukemia: from thymocyte to lymphoblast , 2006, Leukemia.
[4] M. Muckenthaler,et al. Activating NOTCH1 mutations predict favorable early treatment response and long-term outcome in childhood precursor T-cell lymphoblastic leukemia. , 2006, Blood.
[5] Jiong Hu,et al. NOTCH1 Mutations in T-Cell Acute Lymphoblastic Leukemia: Prognostic Significance and Implication in Multifactorial Leukemogenesis , 2006, Clinical Cancer Research.
[6] A. Look,et al. Notch 1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukaemia , 2006, Nature Reviews Cancer.
[7] E. Macintyre,et al. CALM-AF10+ T-ALL expression profiles are characterized by overexpression of HOXA and BMI1 oncogenes , 2005, Leukemia.
[8] H. Sather,et al. Significance of HOX11L2/TLX3 expression in children with T-cell acute lymphoblastic leukemia treated on Children's Cancer Group protocols , 2005, Leukemia.
[9] F. Sigaux,et al. HOXA genes are included in genetic and biologic networks defining human acute T-cell leukemia (T-ALL). , 2005, Blood.
[10] J. Cayuela,et al. Impact of TCR status and genotype on outcome in adult T-cell acute lymphoblastic leukemia: a LALA-94 study. , 2005, Blood.
[11] R. Siebert,et al. Disruption of the BCL11B gene through inv(14)(q11.2q32.31) results in the expression of BCL11B-TRDC fusion transcripts and is associated with the absence of wild-type BCL11B transcripts in T-ALL , 2005, Leukemia.
[12] E. Macintyre,et al. Age-related phenotypic and oncogenic differences in T-cell acute lymphoblastic leukemias may reflect thymic atrophy. , 2004, Blood.
[13] H. Dombret,et al. Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trial. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] Andrew P. Weng,et al. Activating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic Leukemia , 2004, Science.
[15] A. Ferrando,et al. Biallelic transcriptional activation of oncogenic transcription factors in T-cell acute lymphoblastic leukemia. , 2004, Blood.
[16] M. Caligiuri,et al. Prognostic importance of TLX1 (HOX11) oncogene expression in adults with T-cell acute lymphoblastic leukaemia , 2004, The Lancet.
[17] F. Speleman,et al. Clinical significance of HOX11L2 expression linked to t(5;14)(q35;q32), of HOX11 expression, and of SIL-TAL fusion in childhood T-cell malignancies: results of EORTC studies 58881 and 58951. , 2004, Blood.
[18] F. Watzinger,et al. Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using ‘real-time’ quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) – a Europe against cancer program , 2003, Leukemia.
[19] E. Macintyre,et al. CALM-AF10 is a common fusion transcript in T-ALL and is specific to the TCRγδ lineage , 2003 .
[20] N. Heerema,et al. Expression of HOX11 in childhood T-lineage acute lymphoblastic leukaemia can occur in the absence of cytogenetic aberration at 10q24: a study from the Children's Cancer Group (CCG) , 2003, Leukemia.
[21] E. Macintyre,et al. Analysis of TCR, pT alpha, and RAG-1 in T-acute lymphoblastic leukemias improves understanding of early human T-lymphoid lineage commitment. , 2003, Blood.
[22] J. Zucman‐Rossi,et al. HOX11L2 expression defines a clinical subtype of pediatric T-ALL associated with poor prognosis. , 2002, Blood.
[23] L. Foroni,et al. Cytogenetics and molecular genetics of acute lymphoblastic leukemia. , 2002, Reviews in clinical and experimental hematology.
[24] U. Kees,et al. A complex containing PBX2 contributes to activation of the proto-oncogene HOX11. , 2002, Biochemical and biophysical research communications.
[25] E. Lander,et al. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. , 2002, Cancer cell.
[26] R. Heilig,et al. A new recurrent and specific cryptic translocation, t(5;14)(q35;q32), is associated with expression of the Hox11L2 gene in T acute lymphoblastic leukemia , 2001, Leukemia.
[27] U. Kees,et al. Promoter demethylation accompanies reactivation of the HOX11 proto‐oncogene in leukemia , 2000, Genes, chromosomes & cancer.
[28] J. Shuster,et al. New recurring cytogenetic abnormalities and association of blast cell karyotypes with prognosis in childhood T-cell acute lymphoblastic leukemia: a pediatric oncology group report of 343 cases. , 2000, Blood.
[29] J. Peto,et al. Asymptotically Efficient Rank Invariant Test Procedures , 1972 .
[30] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[31] F. Speleman,et al. Novel cryptic chromosomal rearrangements in childhood acute lymphoblastic leukemia detected by multiple color fluorescent in situ hybridization. , 2005, Haematologica.